Five things for pharma marketers to know: Friday, July 12, 2019

CVS is planning to expand stores with additional health services to 10 more markets. CVS HealthHub locations include health services to manage chronic diseases and more health-focused products like blood-testing devices and sleep apnea machines. The expansion plans are scheduled for the first half of 2020. (CNBC)

Reckitt Benckiser will pay $1.4 billion to end opioid probes. The Justice Department was investigating whether former RB subsidiary Indivior carried out an illegal scheme to boost sales of an opioid addiction treatment. It is the largest opioid-related settlement to date. (Reuters)

House committee weighs legalizing marijuana. Members of the the House Judiciary Subcommittee on Crime, Terrorism and Homeland Security discussed decriminalizing and legalizaing pot at the federal level. Eleven states have legalized recreational marijuana use for adults. (CNBC)

Most Americans support making cigarettes less addictive. Eighty-one percent of Americans have said they support changes to make cigarettes with less nicotine, according to data from the Centers for Disease Control and Prevention. In 2010, only about half supported cigarettes with less nicotine. (Time)

The White House has pulled its proposal to end drug rebates. The ban would have forced pharmacy benefit managers to pass rebates to patients instead of keeping the difference as profit. Shares of PBMs, drug distributors and insurers jumped after the announcement. (MM&M)